Biogen Inc. (BIIB)

281.13
4.60 1.70
NASDAQ
Prev Close 276.52
Open 275.15
Day Low/High 274.14 / 281.76
52 Wk Low/High 215.78 / 374.99
Volume 887.61K
Exchange NASDAQ
Shares Outstanding 163.19B
Market Cap 45.51B
P/E Ratio 8.62
Div & Yield N.A. (N.A)
Trader's Notebook: Johnson & Johnson May Be Worth a Look

Trader's Notebook: Johnson & Johnson May Be Worth a Look

And watch out for surprises in the biotech sector.

We're Feeling Better About Growth Stocks

We're Feeling Better About Growth Stocks

Amazon is among the indicators.

Plenty of Good News -- If You Look

Plenty of Good News -- If You Look

Not all growth is hated today.

Jim Cramer Bullish on Microsoft, Likes General Mills and WhiteWave

Jim Cramer Bullish on Microsoft, Likes General Mills and WhiteWave

Jim Cramer answers viewers questions from social media on the floor of the New York Stock Exchange.

Jim Cramer Says GE, PepsiCo, Amazon and Apple Are Stocks to Own

Jim Cramer Says GE, PepsiCo, Amazon and Apple Are Stocks to Own

Jim Cramer discusses why you should own General Electric (GE) and why he's a fan of Columbia Sportswear (COLM) while answering viewers' questions from social media Tuesday.

Biogen's Bullish Charts Foreshadow a Rally

Biogen's Bullish Charts Foreshadow a Rally

A bullish divergence in the technicals points to more upside.

This Is How Big Money Is Made

We lighten up on what we bought when we had courage.

Jim Cramer: Could Glencore Be the Next Long Term Capital?

Jim Cramer: Could Glencore Be the Next Long Term Capital?

Jim Cramer answered viewers’ Twitter (TWTR) questions from the floor of the Stock Exchange and said he's not assuaged by Glencore's (GLCNF) comments that it is ‘operationally and financially robust.'

The Only Rule That Works in This Market

If you want to make money, wait to buy stocks until they're way, way down.

Biogen Takes a Beating

Biogen Takes a Beating

The stock has defined its own purgatory below the gap down from July.

Build a Core Position in Biotech Intrexon at These Lower Prices

Build a Core Position in Biotech Intrexon at These Lower Prices

Following a 40% decline, now looks good for scaling into the stock.

Jim Cramer Says if the Fed Moves There Will Still Be Ways to Make Money

Jim Cramer Says if the Fed Moves There Will Still Be Ways to Make Money

TheStreet's Jim Cramer said he doesn't care when the Federal Reserve decides to raise short-term interest rates, although he would prefer that they stay on the sidelines.

Jim Cramer Says Retail Investors Should Wait to Buy Stocks

Jim Cramer Says Retail Investors Should Wait to Buy Stocks

Stocks climbed early Thursday, but Jim Cramer, portfolio manager of Action Alerts PLUS, remains cautious still.

You Can't Keep Volatility Down Forever

You Can't Keep Volatility Down Forever

We saw this coming, but there's more to the recent turmoil than China.

Keep Calm and Shop for Bargains

Keep Calm and Shop for Bargains

It could be time to deploy some of your dry powder.

It's a Fine Line With S&P Advance/Decline

It's a Fine Line With S&P Advance/Decline

It looks like how Dow transportation average did before it imploded.

This Market Keeps Demoting the Generals

This Market Keeps Demoting the Generals

Disney could become the latest have to join the have-nots.

You Can Run, But You Can't Hide Today

There's no such thing as a 'safe harbor' right now on Wall Street.

Jim Cramer: Allergan Is a Favorite Stock, Teva Deal Was 'Incredible'

Jim Cramer: Allergan Is a Favorite Stock, Teva Deal Was 'Incredible'

Jim Cramer, portfolio manager of Action Alerts PLUS, and research director Jack Mohr sat down to talk about their ‘favorite company in the portfolio:’ Allergan.

Price Isn't a Problem for Gilead Sciences

Price Isn't a Problem for Gilead Sciences

Drugmaker has one of the best showings of earnings season.

Price Isn't a Problem for Gilead Sciences

Price Isn't a Problem for Gilead Sciences

Drugmaker has one of the best showings of earnings season.

Troubled Stocks Go From Worst to First

Troubled Stocks Go From Worst to First

Oil- and commodity-related shares perform well.

Jensen's Morning Musings

I'm happy as always to be standing in for Doug Kass on the Daily Diary. Premarket futures are currently pointing to a slight opening rise. Let's see if we can build on yesterday's rally after previously seeing five straight declining sessions.  Over...

Biogen Stock Remains Deeply Oversold

Biogen Stock Remains Deeply Oversold

Three ways to profit after last Friday's crazy freefall.

Cramer Will Be Watching Twitter and Gilead Earnings on Tuesday

Cramer Will Be Watching Twitter and Gilead Earnings on Tuesday

Jim Cramer is watching Twitter (TWTR) as the social media giant releases earnings for its second quarter on Tuesday, July 28th after the market’s closing bell.

Tread Carefully in the Market

Tread Carefully in the Market

This week could easily bring additional selling.

Cramer: You're Getting a Chance to Buy PayPal Now, Don't Miss Out

Cramer: You're Getting a Chance to Buy PayPal Now, Don't Miss Out

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

Biogen Changed the Perception of This Market

Biogen Changed the Perception of This Market

Its large drop made people take notice of the haves-have-nots divergence.

The Day Was Even Worse Than It Looked

A lot of bad news on a lot of fronts.